Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

Autophagy links antimicrobial activity with antigen presentation in Langerhans cells.

Dang AT, Teles RM, Liu PT, Choi A, Legaspi A, Sarno EN, Ochoa MT, Parvatiyar K, Cheng G, Gilliet M, Bloom BR, Modlin RL.

JCI Insight. 2019 Apr 18;4(8). pii: 126955. doi: 10.1172/jci.insight.126955. eCollection 2019 Apr 18.

2.

IL-26 contributes to host defense against intracellular bacteria.

Dang AT, Teles RM, Weiss DI, Parvatiyar K, Sarno EN, Ochoa MT, Cheng G, Gilliet M, Bloom BR, Modlin RL.

J Clin Invest. 2019 Apr 2;130:1926-1939. doi: 10.1172/JCI99550. eCollection 2019 Apr 2.

3.

Dual RNA-Seq of Human Leprosy Lesions Identifies Bacterial Determinants Linked to Host Immune Response.

Montoya DJ, Andrade P, Silva BJA, Teles RMB, Ma F, Bryson B, Sadanand S, Noel T, Lu J, Sarno E, Arnvig KB, Young D, Lahiri R, Williams DL, Fortune S, Bloom BR, Pellegrini M, Modlin RL.

Cell Rep. 2019 Mar 26;26(13):3574-3585.e3. doi: 10.1016/j.celrep.2019.02.109.

4.

Plasticity of antimicrobial and phagocytic programs in human macrophages.

Montoya D, Mehta M, Ferguson BG, Teles RMB, Krutzik SR, Cruz D, Pellegrini M, Modlin RL.

Immunology. 2019 Feb;156(2):164-173. doi: 10.1111/imm.13013. Epub 2018 Nov 11.

PMID:
30357820
5.

Intrinsic activation of the vitamin D antimicrobial pathway by M. leprae infection is inhibited by type I IFN.

Zavala K, Gottlieb CA, Teles RM, Adams JS, Hewison M, Modlin RL, Liu PT.

PLoS Negl Trop Dis. 2018 Oct 9;12(10):e0006815. doi: 10.1371/journal.pntd.0006815. eCollection 2018 Oct.

6.

Vitamin D status contributes to the antimicrobial activity of macrophages against Mycobacterium leprae.

Kim EW, Teles RMB, Haile S, Liu PT, Modlin RL.

PLoS Negl Trop Dis. 2018 Jul 2;12(7):e0006608. doi: 10.1371/journal.pntd.0006608. eCollection 2018 Jul.

7.

Cell-type deconvolution with immune pathways identifies gene networks of host defense and immunopathology in leprosy.

Inkeles MS, Teles RM, Pouldar D, Andrade PR, Madigan CA, Lopez D, Ambrose M, Noursadeghi M, Sarno EN, Rea TH, Ochoa MT, Iruela-Arispe ML, Swindell WR, Ottenhoff TH, Geluk A, Bloom BR, Pellegrini M, Modlin RL.

JCI Insight. 2016 Sep 22;1(15):e88843. doi: 10.1172/jci.insight.88843.

8.

Jagged1 Instructs Macrophage Differentiation in Leprosy.

Kibbie J, Teles RM, Wang Z, Hong P, Montoya D, Krutzik S, Lee S, Kwon O, Modlin RL, Cruz D.

PLoS Pathog. 2016 Aug 17;12(8):e1005808. doi: 10.1371/journal.ppat.1005808. eCollection 2016 Aug.

9.

IL-27 Suppresses Antimicrobial Activity in Human Leprosy.

Teles RMB, Kelly-Scumpia KM, Sarno EN, Rea TH, Ochoa MT, Cheng G, Modlin RL.

J Invest Dermatol. 2015 Oct;135(10):2410-2417. doi: 10.1038/jid.2015.195. Epub 2015 Jun 1.

10.

Platform for real-time simulation of dynamic systems and hardware-in-the-loop for control algorithms.

de Souza ID, Silva SN, Teles RM, Fernandes MA.

Sensors (Basel). 2014 Oct 15;14(10):19176-99. doi: 10.3390/s141019176.

11.

IL-32 is a molecular marker of a host defense network in human tuberculosis.

Montoya D, Inkeles MS, Liu PT, Realegeno S, Teles RM, Vaidya P, Munoz MA, Schenk M, Swindell WR, Chun R, Zavala K, Hewison M, Adams JS, Horvath S, Pellegrini M, Bloom BR, Modlin RL.

Sci Transl Med. 2014 Aug 20;6(250):250ra114. doi: 10.1126/scitranslmed.3009546.

12.

Comparison of molecular signatures from multiple skin diseases identifies mechanisms of immunopathogenesis.

Inkeles MS, Scumpia PO, Swindell WR, Lopez D, Teles RMB, Graeber TG, Meller S, Homey B, Elder JT, Gilliet M, Modlin RL, Pellegrini M.

J Invest Dermatol. 2015 Jan;135(1):151-159. doi: 10.1038/jid.2014.352. Epub 2014 Aug 11.

13.

Type I interferon suppresses type II interferon-triggered human anti-mycobacterial responses.

Teles RM, Graeber TG, Krutzik SR, Montoya D, Schenk M, Lee DJ, Komisopoulou E, Kelly-Scumpia K, Chun R, Iyer SS, Sarno EN, Rea TH, Hewison M, Adams JS, Popper SJ, Relman DA, Stenger S, Bloom BR, Cheng G, Modlin RL.

Science. 2013 Mar 22;339(6126):1448-53. doi: 10.1126/science.1233665. Epub 2013 Feb 28.

14.

Different immunosuppressive mechanisms in multi-drug-resistant tuberculosis and non-tuberculous mycobacteria patients.

Pinheiro RO, de Oliveira EB, Dos Santos G, Sperandio da Silva GM, de Andrade Silva BJ, Teles RM, Milagres A, Sarno EN, Dalcolmo MP, Sampaio EP.

Clin Exp Immunol. 2013 Feb;171(2):210-9. doi: 10.1111/cei.12007.

15.

Galectin-3 regulates the innate immune response of human monocytes.

Chung AW, Sieling PA, Schenk M, Teles RM, Krutzik SR, Hsu DK, Liu FT, Sarno EN, Rea TH, Stenger S, Modlin RL, Lee DJ.

J Infect Dis. 2013 Mar 15;207(6):947-56. doi: 10.1093/infdis/jis920. Epub 2012 Dec 18.

16.

The helicase DDX41 recognizes the bacterial secondary messengers cyclic di-GMP and cyclic di-AMP to activate a type I interferon immune response.

Parvatiyar K, Zhang Z, Teles RM, Ouyang S, Jiang Y, Iyer SS, Zaver SA, Schenk M, Zeng S, Zhong W, Liu ZJ, Modlin RL, Liu YJ, Cheng G.

Nat Immunol. 2012 Dec;13(12):1155-61. doi: 10.1038/ni.2460. Epub 2012 Nov 11.

17.

NOD2 triggers an interleukin-32-dependent human dendritic cell program in leprosy.

Schenk M, Krutzik SR, Sieling PA, Lee DJ, Teles RM, Ochoa MT, Komisopoulou E, Sarno EN, Rea TH, Graeber TG, Kim S, Cheng G, Modlin RL.

Nat Med. 2012 Mar 25;18(4):555-63. doi: 10.1038/nm.2650.

18.

Interleukin-4 regulates the expression of CD209 and subsequent uptake of Mycobacterium leprae by Schwann cells in human leprosy.

Teles RM, Krutzik SR, Ochoa MT, Oliveira RB, Sarno EN, Modlin RL.

Infect Immun. 2010 Nov;78(11):4634-43. doi: 10.1128/IAI.00454-10. Epub 2010 Aug 16.

19.

Schwann cells producing matrix metalloproteinases under Mycobacterium leprae stimulation may play a role in the outcome of leprous neuropathy.

Oliveira AL, Antunes SL, Teles RM, Costa da Silva AC, Silva TP, Brandão Teles R, Ferreira Medeiros M, Britto C, Jardim MR, Pereira Sampaio E, Nunes Sarno E.

J Neuropathol Exp Neurol. 2010 Jan;69(1):27-39. doi: 10.1097/NEN.0b013e3181c6515c.

PMID:
20010305
20.

High matrix metalloproteinase production correlates with immune activation and leukocyte migration in leprosy reactional lesions.

Teles RM, Teles RB, Amadeu TP, Moura DF, Mendonça-Lima L, Ferreira H, Santos IM, Nery JA, Sarno EN, Sampaio EP.

Infect Immun. 2010 Mar;78(3):1012-21. doi: 10.1128/IAI.00896-09. Epub 2009 Dec 14.

21.

Divergence of macrophage phagocytic and antimicrobial programs in leprosy.

Montoya D, Cruz D, Teles RM, Lee DJ, Ochoa MT, Krutzik SR, Chun R, Schenk M, Zhang X, Ferguson BG, Burdick AE, Sarno EN, Rea TH, Hewison M, Adams JS, Cheng G, Modlin RL.

Cell Host Microbe. 2009 Oct 22;6(4):343-53. doi: 10.1016/j.chom.2009.09.002.

22.

Expression of metalloproteinases (MMP-2, MMP-9, and TACE) and TNF-alpha in the nerves of leprosy patients.

Teles RM, Antunes SL, Jardim MR, Oliveira AL, Nery JA, Sales AM, Sampaio EP, Shubayev V, Sarno EN.

J Peripher Nerv Syst. 2007 Sep;12(3):195-204.

PMID:
17868246
23.

Ninjurin 1 asp110ala single nucleotide polymorphism is associated with protection in leprosy nerve damage.

Cardoso CC, Martinez AN, Guimarães PE, Mendes CT, Pacheco AG, de Oliveira RB, Teles RM, Illarramendi X, Sampaio EP, Sarno EN, Dias-Neto E, Moraes MO.

J Neuroimmunol. 2007 Oct;190(1-2):131-8. Epub 2007 Sep 6.

PMID:
17825431
24.

Long-term culture of multibacillary leprosy macrophages isolated from skin lesions: a new model to study Mycobacterium leprae-human cell interaction.

Moura DF, Teles RM, Ribeiro-Carvalho MM, Teles RB, Santos IM, Ferreira H, Fulco TO, Nery JA, Sampaio EP, Sarno EN.

Br J Dermatol. 2007 Aug;157(2):273-83. Epub 2007 Jun 6.

PMID:
17553031
25.

Cytokines and Mycobacterium leprae induce apoptosis in human Schwann cells.

Oliveira RB, Sampaio EP, Aarestrup F, Teles RM, Silva TP, Oliveira AL, Antas PR, Sarno EN.

J Neuropathol Exp Neurol. 2005 Oct;64(10):882-90.

PMID:
16215460
26.

Differential TNFalpha mRNA regulation detected in the epidermis of leprosy patients.

Teles RM, Moraes MO, Geraldo NT, Salles AM, Sarno EN, Sampaio EP.

Arch Dermatol Res. 2002 Nov;294(8):355-62. Epub 2002 Sep 26.

PMID:
12420104
27.

Anti-inflammatory drugs block cytokine mRNA accumulation in the skin and improve the clinical condition of reactional leprosy patients.

Moraes MO, Sarno EN, Teles RM, Almeida AS, Saraiva BC, Nery JA, Sampaio EP.

J Invest Dermatol. 2000 Dec;115(6):935-41.

28.

[Expectations of hospitalized patients as to their relationship with the nursing team].

Miranda AC, Teixeira MS, Santos RB, Teles RM.

Rev Bras Enferm. 1997 Apr-Jun;50(2):183-96. Portuguese.

PMID:
9775932

Supplemental Content

Loading ...
Support Center